Angiogenesis inhibitors: what is the clinical future?
Verheul
Henk M W
HM
Department of Medical Oncology, Johns Hopkins University, 1650 Orleans Street CRB 162, Baltimore, MD 21231, USA. hverheul@jhmi.edu
Pinedo
Henk M W
HM
D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D002448:Cell Adhesion / Q000187:drug effects; D015195:Drug Design; D042783:Endothelial Cells / Q000187:drug effects; D006801:Humans; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy*; D009389:Neovascularization, Pathologic / Q000517:prevention & control*
D020533:Angiogenesis Inhibitors